All In Biotech

Drug Trial Radar · NCT03880825

Drug Interaction Study of Levoketoconazole and Metformin

A Phase I Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Study to Evaluate the Effect of Levoketoconazole on the Single-Dose Pharmacokinetics of Metformin in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Aug 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Mar 28, 2019

Primary completion

May 3, 2019

Study completion May 3, 2019

Sponsor

Lead sponsor
Cortendo ABIndustry
Sponsor type
Industry
First posted
Mar 19, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.

Conditions

  • Healthy Subjects

Interventions

  • Metformin 500 mg Oral TabletDrug

    single dose

  • Levoketoconazole 150 - 600 mg (BID)Drug

    escalating dose from 150 mg to 600 mg (BID)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax) of metforminTime frame: 48 hours
  2. Time to maximum concentration (Tmax) of metforminTime frame: 48 hours
  3. Area under the plasma concentration-time curve (AUC) of metforminTime frame: 48 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinical Pharmacology of Miami, LLC

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.